Concordia Healthcare Corp (TSE:CXR) had its price objective raised by equities researchers at TD Securities from C$7.00 to C$14.00 in a note issued to investors on Monday. The firm currently has a “hold” rating on the stock. TD Securities’ target price suggests a potential upside of 106.49% from the company’s current price.

Several other analysts also recently issued reports on CXR. Royal Bank Of Canada reiterated an “outperform” rating and set a C$73.00 price target on shares of Concordia Healthcare Corp in a research note on Thursday, May 26th. Goldman Sachs Group Inc. started coverage on Concordia Healthcare Corp in a research note on Tuesday, June 7th. They set a “neutral” rating and a C$42.00 price target for the company. Finally, CIBC downgraded Concordia Healthcare Corp from a “sector perform” rating to an “underperform” rating in a research note on Monday, August 15th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus price target of C$27.25.

Concordia Healthcare Corp (TSE:CXR) opened at 6.78 on Monday. The stock’s market capitalization is $345.90 million. Concordia Healthcare Corp has a 52 week low of $6.33 and a 52 week high of $92.11. The firm has a 50-day moving average of $12.88 and a 200 day moving average of $28.09.

Receive News & Ratings for Concordia Healthcare Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concordia Healthcare Corp and related companies with MarketBeat.com's FREE daily email newsletter.